<DOC>
	<DOCNO>NCT00591656</DOCNO>
	<brief_summary>The purpose study determine therapeutic efficacy complication systemic consolidation therapy paclitaxel plus carboplatin follow primary chemoradiation locally advanced cervical cancer .</brief_summary>
	<brief_title>Systemic Consolidation Therapy After Primary Chemoradiation Therapy Locally Advanced Cervical Cancer</brief_title>
	<detailed_description>Systemic consolidation therapy paclitaxel plus carboplatin ( 3 cycle per 3 week ) follow primary chemoradiation ( 3 cycle per 3 week ) locally advanced cervical cancer elevate therapeutic efficacy remove microscopic metastatic lesion could identify naked eye diagnostic imaging test .</detailed_description>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<criteria>patient underwent three cycle concurrent chemoradiation therapy paclitaxel carboplatin nonsmall cell type cervical cancer stage IB2 , bulky size ( &gt; 4cm ) IIA , IIBIVA 20 year GOG performance status 02 Informed consent Platelet &gt; 100K , Hb &gt; 10.0 g/dl , ANC &gt; 1500/mm3 , Cr &lt; 1.25*upper normal limit , bilirubin &lt; 1.5mg/dl , AST &amp; ALT &lt; *3 upper normal limit Expected life &gt; 6 month Peripheral neurotoxicity &gt; NCI CTCAE grade 2 Sever infection Previous history chemotherapy radiation therapy Pleural effusion , pericardial effusion , ascites could cause dyspnea &gt; NCI grade 2 Paraaortic lymph node metastasis Allergy platinum Previous history atrial ventricular arrhythmia congestive heart failure Uncontrolled infection , diabetes mellitus , hypertension , ischemic heart disease , myocardiac infarct within 6 month Severe disease acute chronic renal failure acute cerebral infarct , cerebral hemorrhage , recurrent hepatitis , liver cirrhosis , unknown fever 39 degree centigrade</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2007</verification_date>
</DOC>